Home
Discovery Engines
Team
Portfolio
Offices
News
← View Portfolio
Bright Peak is developing next-generation engineered cytokines for immuno-oncology indications.
Company Name
Bright Peak Therapeutics
Location
Basel, Switzerland
Connected News
Bright Peak Therapeutics Announces $107 Million Series B Financing and Expanded Board of Directors
Versant Ventures Launches Bright Peak Therapeutics